tiprankstipranks
DocCheck AG (DE:AJ91)
XETRA:AJ91
Germany Market

DocCheck AG (AJ91) Stock Price & Analysis

1 Followers

AJ91 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€7.70 - €13.30
Previous Close€9.25
Volume1.12K
Average Volume (3M)561.00
Market Cap
€46.56M
Enterprise Value€31.71M
Total Cash (Recent Filing)€15.71M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)7.7
Beta0.75
May 10, 2024
EPS EstimateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)1.17
Shares Outstanding5,073,816
10 Day Avg. Volume295
30 Day Avg. Volume561
Standard Deviation0.12
R-Squared0.00056
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

AJ91 FAQ

What was DocCheck AG’s price range in the past 12 months?
DocCheck AG lowest stock price was €7.70 and its highest was €13.30 in the past 12 months.
    What is DocCheck AG’s market cap?
    Currently, no data Available
    When is DocCheck AG’s upcoming earnings report date?
    DocCheck AG’s upcoming earnings report date is May 10, 2024 which is in 43 days.
      How were DocCheck AG’s earnings last quarter?
      Currently, no data Available
      Is DocCheck AG overvalued?
      According to Wall Street analysts DocCheck AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does DocCheck AG pay dividends?
        DocCheck AG pays a Annually dividend of €0.75 which represents an annual dividend yield of 8.33%. See more information on DocCheck AG dividends here
          What is DocCheck AG’s EPS estimate?
          DocCheck AG’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does DocCheck AG have?
          DocCheck AG has 5,033,876 shares outstanding.
            What happened to DocCheck AG’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of DocCheck AG?
            Currently, no hedge funds are holding shares in DE:AJ91
            ---

            DocCheck AG Stock Smart Score

            4
            Neutral
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -22.87%
            12-Months-Change

            Fundamentals

            Return on Equity
            16.54%
            Trailing 12-Months
            Asset Growth
            6.72%
            Trailing 12-Months

            Company Description

            DocCheck AG

            DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
            ---
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis